SG10201706609XA - Piperaquine microcapsules and compositions containing them - Google Patents

Piperaquine microcapsules and compositions containing them

Info

Publication number
SG10201706609XA
SG10201706609XA SG10201706609XA SG10201706609XA SG10201706609XA SG 10201706609X A SG10201706609X A SG 10201706609XA SG 10201706609X A SG10201706609X A SG 10201706609XA SG 10201706609X A SG10201706609X A SG 10201706609XA SG 10201706609X A SG10201706609X A SG 10201706609XA
Authority
SG
Singapore
Prior art keywords
compositions containing
piperaquine
microcapsules
piperaquine microcapsules
compositions
Prior art date
Application number
SG10201706609XA
Other languages
English (en)
Inventor
Christian Stollberg
Giancarla Bianchi
Flavio Fabiani
Luigi Boltri
Original Assignee
Adare Pharmaceuticals S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adare Pharmaceuticals S R L filed Critical Adare Pharmaceuticals S R L
Publication of SG10201706609XA publication Critical patent/SG10201706609XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
SG10201706609XA 2013-03-22 2014-03-21 Piperaquine microcapsules and compositions containing them SG10201706609XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361804448P 2013-03-22 2013-03-22

Publications (1)

Publication Number Publication Date
SG10201706609XA true SG10201706609XA (en) 2017-09-28

Family

ID=51789429

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201507843TA SG11201507843TA (en) 2013-03-22 2014-03-21 Piperaquine microcapsules and compositions containing them
SG10201706609XA SG10201706609XA (en) 2013-03-22 2014-03-21 Piperaquine microcapsules and compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201507843TA SG11201507843TA (en) 2013-03-22 2014-03-21 Piperaquine microcapsules and compositions containing them

Country Status (14)

Country Link
US (2) US9668979B2 (zh)
EP (1) EP2976069B1 (zh)
JP (1) JP6345762B2 (zh)
KR (1) KR20150133267A (zh)
CN (1) CN105228597B (zh)
AU (1) AU2014234258B2 (zh)
BR (1) BR112015024359B1 (zh)
CA (1) CA2907628C (zh)
ES (1) ES2809254T3 (zh)
MX (1) MX354453B (zh)
PL (1) PL2976069T3 (zh)
PT (1) PT2976069T (zh)
SG (2) SG11201507843TA (zh)
WO (1) WO2014147242A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104814931B (zh) * 2015-04-14 2017-12-26 华南农业大学 一种喹乙醇缓释颗粒及其制备方法和应用
US20180256515A1 (en) 2017-03-10 2018-09-13 Adare Pharmaceuticals, Inc. Oral amphetamine composition
CN114343230B (zh) * 2022-02-10 2023-05-12 湖北中烟工业有限责任公司 一种薄片添加剂、其制备方法及含有该薄片添加剂的烟草薄片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
PT1898901T (pt) * 2005-05-18 2017-02-27 Sun Pharmaceutical Ind Ltd Formas de dosagem estáveis de antimaláricos de espiro- e diespiro-1,2,4-trioxolano
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
NZ600256A (en) * 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them

Also Published As

Publication number Publication date
CN105228597A (zh) 2016-01-06
PT2976069T (pt) 2020-08-05
US9668979B2 (en) 2017-06-06
US20160045447A1 (en) 2016-02-18
MX354453B (es) 2018-03-05
SG11201507843TA (en) 2015-10-29
CN105228597B (zh) 2019-03-26
AU2014234258A1 (en) 2015-10-08
JP6345762B2 (ja) 2018-06-20
EP2976069A1 (en) 2016-01-27
BR112015024359A2 (pt) 2017-07-18
MX2015013470A (es) 2016-06-02
BR112015024359B1 (pt) 2022-09-13
WO2014147242A1 (en) 2014-09-25
CA2907628A1 (en) 2014-09-25
WO2014147242A8 (en) 2015-11-05
ES2809254T3 (es) 2021-03-03
PL2976069T3 (pl) 2020-10-19
KR20150133267A (ko) 2015-11-27
EP2976069B1 (en) 2020-05-06
US20140322296A1 (en) 2014-10-30
CA2907628C (en) 2021-11-16
AU2014234258B2 (en) 2019-02-14
JP2016514720A (ja) 2016-05-23

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and their uses
HK1215538A1 (zh) 含有防曬劑的微膠囊
IL244850A0 (en) Stabilized epinaconazole preparations, and their uses
ZA201600067B (en) Intumescent composition
GB201303690D0 (en) Microcapsules and contrete containing the same
GB201413353D0 (en) Compositions and methods
EP2953474A4 (en) COMPOSITIONS AND METHODS
GB201308072D0 (en) Compositions and methods
GB201323008D0 (en) Compounds and uses thereof
GB201321693D0 (en) Composition and uses thereof
IL240248A0 (en) Met-binding substances and their uses
IL276126B (en) Preparations containing l-4-chloroquinonerine and their uses
GB201305813D0 (en) Compositions and methods
GB201307233D0 (en) Compounds and uses thereof
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
HK1223307A1 (zh) 新型化合物和其用途
GB201309180D0 (en) Compounds and Their Uses
SG10201706609XA (en) Piperaquine microcapsules and compositions containing them
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201305297D0 (en) Novel agents and uses thereof
GB201323005D0 (en) Compounds and uses thereof
GB201308242D0 (en) Compositions and uses thereof
GB201320161D0 (en) Compounds and their uses